Department of Cardiology National University Heart Centre Singapore.
Yong Loo Lin School of Medicine National University of Singapore Singapore.
J Am Heart Assoc. 2024 Aug 20;13(16):e034133. doi: 10.1161/JAHA.123.034133. Epub 2024 Jul 31.
NULL-PLEASE is a simple and accurate clinical scoring system developed in a Western cohort of patients with out-of-hospital cardiac arrest (OHCA). The need for blood test results limits its use in early stages of care. We adapted and validated the NULL-EASE score (without laboratory tests) in an independent, multiethnic Asian cohort of patients with out-of-hospital cardiac arrest.
Using the Singapore OHCA registry, we included consecutive adult patients with out-of-hospital cardiac arrest who survived to hospital admission between April 2010 to December 2020. In-hospital mortality was the primary outcome. Logistic regression analyses were performed with STATA MP v18. Of 3274 patients (median age 64, interquartile range 54-75; 67.9% male) included in the study, 2476 (75.6%) had in-hospital mortality. NULL-EASE score was significantly lower in survivors compared with nonsurvivors (median [inter quartile range] 3 [1-4] versus 6 [4-7]; <0.001) and strongly predictive of mortality (area under receiver operating characteristic, 0.81 [95% CI, 0.79-0.83]). Patients with a score of ≥3 had higher odds of mortality (adjusted odds ratio, 8.11 [95% CI, 6.57-10.00]) when compared with those with lower scores, after adjusting for sex, residential arrest, diabetes, respiratory disease, and stroke. A cutoff value of ≥3 predicted mortality with 92.2% sensitivity, 84.1% positive predictive value, 46.1% specificity, and 65.5% negative predictive value. NULL-EASE score performed better in younger compared with older patients (area under receiver operating characteristic, 0.82 versus 0.77, =0.008).
The NULL-EASE score has good discriminative performance (sensitivity and accuracy) in our multiethnic Asian cohort, but the cutoff of ≥3 falls short of the desired level of specificity for therapeutic decision-making.
NULL-PLEASE 是一种简单而准确的临床评分系统,在西方院外心脏骤停(OHCA)患者队列中开发。需要血液检测结果限制了其在护理早期的使用。我们在一个独立的、多民族的亚洲院外心脏骤停患者队列中对 NULL-EASE 评分(不包括实验室检查)进行了改编和验证。
利用新加坡 OHCA 登记处,我们纳入了 2010 年 4 月至 2020 年 12 月期间存活至住院的连续成年 OHCA 患者。住院死亡率为主要结局。使用 STATA MP v18 进行逻辑回归分析。在纳入的 3274 例患者(中位年龄 64 岁,四分位距 54-75 岁;67.9%为男性)中,2476 例(75.6%)患者住院期间死亡。幸存者的 NULL-EASE 评分明显低于非幸存者(中位数[四分位距] 3 [1-4] 与 6 [4-7];<0.001),并且强烈预测死亡率(接受者操作特征曲线下面积,0.81 [95%CI,0.79-0.83])。与评分较低的患者相比,评分≥3 的患者死亡的可能性更高(调整后的优势比,8.11 [95%CI,6.57-10.00]),同时调整了性别、住所逮捕、糖尿病、呼吸道疾病和中风。截断值≥3 预测死亡率的灵敏度为 92.2%,阳性预测值为 84.1%,特异性为 46.1%,阴性预测值为 65.5%。与年龄较大的患者相比,NULL-EASE 评分在年轻患者中的表现更好(接受者操作特征曲线下面积,0.82 与 0.77,=0.008)。
NULL-EASE 评分在我们的多民族亚洲队列中具有良好的判别性能(灵敏度和准确性),但≥3 的截断值在治疗决策方面的特异性达不到理想水平。